BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30224186)

  • 1. Chemoembolisation with polyvinyl alcohol for advanced hepatocellular carcinoma with portal vein tumour thrombosis and arterioportal shunts: efficacy and prognostic factors.
    Xiao L; Liu Q; Zhao W; Pang H; Zeng Q; Chen Y; Zhao J; Mei Q; He X
    Clin Radiol; 2018 Dec; 73(12):1056.e17-1056.e22. PubMed ID: 30224186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.
    Yang Z; Zou R; Zheng Y; Qiu J; Shen J; Liao Y; Zhang Y; Wang C; Wang Y; Yuan Y; Li K; Zuo D; He W; Liu W; Li B; Yuan Y
    Eur Radiol; 2019 Nov; 29(11):5752-5762. PubMed ID: 30993438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma.
    Lee JW; Hwang SH; Kim DY; Han KH; Yun M
    Clin Nucl Med; 2017 Jan; 42(1):e35-e40. PubMed ID: 27775940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus.
    Pan T; Li XS; Xie QK; Wang JP; Li W; Wu PH; Zhao M
    Clin Radiol; 2014 Dec; 69(12):e553-61. PubMed ID: 25304928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyvinyl alcohol terminal chemoembolization for hepatocellular carcinoma with hepatic arteriovenous shunts: Safety, efficacy, and prognostic factors.
    Liu QS; Mei QL; Li YH
    Eur J Radiol; 2017 Apr; 89():277-283. PubMed ID: 27908612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J; Zheng JS; Sun B; Lu N
    Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoembolization as first-line treatment for hepatocellular carcinoma invading segmental portal vein with tumour burden limited to a monosegmental level.
    Hwang H; Kim JH; Ko E; Kim JY; Ko HK; Gwon DI; Shin JH; Kim GH; Chu HH
    Br J Radiol; 2024 May; 97(1157):1038-1043. PubMed ID: 38445658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.
    Kim GA; Shim JH; Yoon SM; Jung J; Kim JH; Ryu MH; Ryoo BY; Kang YK; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
    J Vasc Interv Radiol; 2015 Mar; 26(3):320-9.e6. PubMed ID: 25612807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics.
    Jia L; Kiryu S; Watadani T; Akai H; Yamashita H; Akahane M; Ohtomo K
    Acta Med Okayama; 2012; 66(2):131-41. PubMed ID: 22525471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
    Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
    J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
    World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis: prognostic factors in a single-center study of 188 patients.
    Liu L; Zhang C; Zhao Y; Qi X; Chen H; Bai W; He C; Guo W; Yin Z; Fan D; Han G
    Biomed Res Int; 2014; 2014():194278. PubMed ID: 24800212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.
    Zhang L; Sun JH; Hou ZH; Zhong BY; Yang MJ; Zhou GH; Wang WS; Huang P; Zhang S; Li Z; Zhu XL; Yan ZP; Ni CF
    Cardiovasc Intervent Radiol; 2021 Jan; 44(1):63-72. PubMed ID: 32965582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three-dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus.
    Su F; Chen KH; Liang ZG; Wu CH; Li L; Qu S; Chen L; Zhu XD; Zhong JH; Li LQ; Xiang BD
    Cancer Med; 2018 Sep; 7(9):4387-4395. PubMed ID: 30062844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
    Mähringer-Kunz A; Steinle V; Düber C; Weinmann A; Koch S; Schmidtmann I; Schotten S; Hinrichs JB; Graafen D; Pinto Dos Santos D; Galle PR; Kloeckner R
    Liver Int; 2019 Feb; 39(2):324-331. PubMed ID: 30318826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative Adjuvant Trans-Arterial Chemoembolization for Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus.
    Liu S; Guo L; Li H; Zhang B; Sun J; Zhou C; Zhou J; Fan J; Ye Q
    Ann Surg Oncol; 2018 Jul; 25(7):2098-2104. PubMed ID: 29728879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: safety, efficacy, and prognostic factors.
    Chern MC; Chuang VP; Liang CT; Lin ZH; Kuo TM
    J Vasc Interv Radiol; 2014 Jan; 25(1):32-40. PubMed ID: 24290099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.